Literature DB >> 26286698

Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.

Pavan Bhargava1, Sonya U Steele1, Emmanuelle Waubant2, Nisha R Revirajan2, Jacqueline Marcus2, Marieme Dembele1, Sandra D Cassard1, Bruce W Hollis3, Ciprian Crainiceanu4, Ellen M Mowry5.   

Abstract

BACKGROUND: Vitamin D insufficiency is a risk factor for multiple sclerosis (MS), and patients do not always show the expected response to vitamin D supplementation.
OBJECTIVE: We aimed to determine if vitamin D supplementation leads to a similar increase in serum 25-hydroxyvitamin-D (25(OH)D) levels in patients with MS and healthy controls (HCs).
METHODS: Participants in this open-label study were female, white, aged 18-60 years, had 25(OH)D levels ⩽ 75 nmol/l at screening, and had relapsing-remitting MS (RRMS) or were HCs. Participants received 5000 IU/day of vitamin D3 for 90 days. Utilizing generalized estimating equations we examined the relationship between the primary outcome (serum 25(OH)D level) and the primary (MS versus HC status) and secondary predictors.
RESULTS: For this study 27 MS patients and 30 HCs were enrolled. There was no significant difference in baseline 25(OH)D level or demographics except for higher body mass index (BMI) in the MS group (25.3 vs. 23.6 kg/m(2), p=0.035). In total, 24 MS subjects and 29 HCs completed the study. In a multivariate model accounting for BMI, medication adherence, and oral contraceptive use, MS patients had a 16.7 nmol/l (95%CI: 4.2, 29.2, p=0.008) lower increase in 25(OH)D levels compared with HCs.
CONCLUSIONS: Patients with MS had a lower increase in 25(OH)D levels with supplementation, even after accounting for putative confounders.
© The Author(s), 2015.

Entities:  

Keywords:  Multiple sclerosis; nutrition; pharmacokinetics; vitamin D supplementation

Mesh:

Substances:

Year:  2015        PMID: 26286698      PMCID: PMC4758937          DOI: 10.1177/1352458515600248

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  32 in total

1.  Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and nonvegetarians: the Adventist Health Study-2.

Authors:  Jacqueline Chan; Karen Jaceldo-Siegl; Gary E Fraser
Journal:  Am J Clin Nutr       Date:  2009-04-01       Impact factor: 7.045

2.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

Authors: 
Journal:  Nat Genet       Date:  2009-06-14       Impact factor: 38.330

3.  Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.

Authors:  Ellen M Mowry; Lauren B Krupp; Maria Milazzo; Dorothee Chabas; Jonathan B Strober; Anita L Belman; Jamie C McDonald; Jorge R Oksenberg; Peter Bacchetti; Emmanuelle Waubant
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

4.  1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.

Authors:  Sneha Joshi; Luiz-Carlos Pantalena; Xikui K Liu; Sarah L Gaffen; Hong Liu; Christine Rohowsky-Kochan; Kenji Ichiyama; Akihiko Yoshimura; Lawrence Steinman; Sylvia Christakos; Sawsan Youssef
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

5.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis.

Authors:  J M Lemire; D C Archer
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

6.  Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.

Authors:  Steve Simpson; Bruce Taylor; Leigh Blizzard; Anne-Louise Ponsonby; Fotini Pittas; Helen Tremlett; Terence Dwyer; Peter Gies; Ingrid van der Mei
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

Review 7.  Vitamin D3: a helpful immuno-modulator.

Authors:  Michelino Di Rosa; Michele Malaguarnera; Ferdinando Nicoletti; Lucia Malaguarnera
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

8.  Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.

Authors:  G S Hiremath; D Cettomai; M Baynes; J N Ratchford; S Newsome; D Harrison; D Kerr; B M Greenberg; P A Calabresi
Journal:  Mult Scler       Date:  2009-04-21       Impact factor: 6.312

Review 9.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

10.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

Authors:  Stephen Sawcer; Garrett Hellenthal; Matti Pirinen; Chris C A Spencer; Nikolaos A Patsopoulos; Loukas Moutsianas; Alexander Dilthey; Zhan Su; Colin Freeman; Sarah E Hunt; Sarah Edkins; Emma Gray; David R Booth; Simon C Potter; An Goris; Gavin Band; Annette Bang Oturai; Amy Strange; Janna Saarela; Céline Bellenguez; Bertrand Fontaine; Matthew Gillman; Bernhard Hemmer; Rhian Gwilliam; Frauke Zipp; Alagurevathi Jayakumar; Roland Martin; Stephen Leslie; Stanley Hawkins; Eleni Giannoulatou; Sandra D'alfonso; Hannah Blackburn; Filippo Martinelli Boneschi; Jennifer Liddle; Hanne F Harbo; Marc L Perez; Anne Spurkland; Matthew J Waller; Marcin P Mycko; Michelle Ricketts; Manuel Comabella; Naomi Hammond; Ingrid Kockum; Owen T McCann; Maria Ban; Pamela Whittaker; Anu Kemppinen; Paul Weston; Clive Hawkins; Sara Widaa; John Zajicek; Serge Dronov; Neil Robertson; Suzannah J Bumpstead; Lisa F Barcellos; Rathi Ravindrarajah; Roby Abraham; Lars Alfredsson; Kristin Ardlie; Cristin Aubin; Amie Baker; Katharine Baker; Sergio E Baranzini; Laura Bergamaschi; Roberto Bergamaschi; Allan Bernstein; Achim Berthele; Mike Boggild; Jonathan P Bradfield; David Brassat; Simon A Broadley; Dorothea Buck; Helmut Butzkueven; Ruggero Capra; William M Carroll; Paola Cavalla; Elisabeth G Celius; Sabine Cepok; Rosetta Chiavacci; Françoise Clerget-Darpoux; Katleen Clysters; Giancarlo Comi; Mark Cossburn; Isabelle Cournu-Rebeix; Mathew B Cox; Wendy Cozen; Bruce A C Cree; Anne H Cross; Daniele Cusi; Mark J Daly; Emma Davis; Paul I W de Bakker; Marc Debouverie; Marie Beatrice D'hooghe; Katherine Dixon; Rita Dobosi; Bénédicte Dubois; David Ellinghaus; Irina Elovaara; Federica Esposito; Claire Fontenille; Simon Foote; Andre Franke; Daniela Galimberti; Angelo Ghezzi; Joseph Glessner; Refujia Gomez; Olivier Gout; Colin Graham; Struan F A Grant; Franca Rosa Guerini; Hakon Hakonarson; Per Hall; Anders Hamsten; Hans-Peter Hartung; Rob N Heard; Simon Heath; Jeremy Hobart; Muna Hoshi; Carmen Infante-Duarte; Gillian Ingram; Wendy Ingram; Talat Islam; Maja Jagodic; Michael Kabesch; Allan G Kermode; Trevor J Kilpatrick; Cecilia Kim; Norman Klopp; Keijo Koivisto; Malin Larsson; Mark Lathrop; Jeannette S Lechner-Scott; Maurizio A Leone; Virpi Leppä; Ulrika Liljedahl; Izaura Lima Bomfim; Robin R Lincoln; Jenny Link; Jianjun Liu; Aslaug R Lorentzen; Sara Lupoli; Fabio Macciardi; Thomas Mack; Mark Marriott; Vittorio Martinelli; Deborah Mason; Jacob L McCauley; Frank Mentch; Inger-Lise Mero; Tania Mihalova; Xavier Montalban; John Mottershead; Kjell-Morten Myhr; Paola Naldi; William Ollier; Alison Page; Aarno Palotie; Jean Pelletier; Laura Piccio; Trevor Pickersgill; Fredrik Piehl; Susan Pobywajlo; Hong L Quach; Patricia P Ramsay; Mauri Reunanen; Richard Reynolds; John D Rioux; Mariaemma Rodegher; Sabine Roesner; Justin P Rubio; Ina-Maria Rückert; Marco Salvetti; Erika Salvi; Adam Santaniello; Catherine A Schaefer; Stefan Schreiber; Christian Schulze; Rodney J Scott; Finn Sellebjerg; Krzysztof W Selmaj; David Sexton; Ling Shen; Brigid Simms-Acuna; Sheila Skidmore; Patrick M A Sleiman; Cathrine Smestad; Per Soelberg Sørensen; Helle Bach Søndergaard; Jim Stankovich; Richard C Strange; Anna-Maija Sulonen; Emilie Sundqvist; Ann-Christine Syvänen; Francesca Taddeo; Bruce Taylor; Jenefer M Blackwell; Pentti Tienari; Elvira Bramon; Ayman Tourbah; Matthew A Brown; Ewa Tronczynska; Juan P Casas; Niall Tubridy; Aiden Corvin; Jane Vickery; Janusz Jankowski; Pablo Villoslada; Hugh S Markus; Kai Wang; Christopher G Mathew; James Wason; Colin N A Palmer; H-Erich Wichmann; Robert Plomin; Ernest Willoughby; Anna Rautanen; Juliane Winkelmann; Michael Wittig; Richard C Trembath; Jacqueline Yaouanq; Ananth C Viswanathan; Haitao Zhang; Nicholas W Wood; Rebecca Zuvich; Panos Deloukas; Cordelia Langford; Audrey Duncanson; Jorge R Oksenberg; Margaret A Pericak-Vance; Jonathan L Haines; Tomas Olsson; Jan Hillert; Adrian J Ivinson; Philip L De Jager; Leena Peltonen; Graeme J Stewart; David A Hafler; Stephen L Hauser; Gil McVean; Peter Donnelly; Alastair Compston
Journal:  Nature       Date:  2011-08-10       Impact factor: 49.962

View more
  14 in total

Review 1.  Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis.

Authors:  Wei Zhen Yeh; Melissa Gresle; Vilija Jokubaitis; Jim Stankovich; Anneke van der Walt; Helmut Butzkueven
Journal:  Br J Pharmacol       Date:  2020-08-05       Impact factor: 8.739

2.  Assessing the values of circulating immune complexes in multiple sclerosis patients following immunomodulator or corticosteroid treatment.

Authors:  Any Docu Axelerad; Alina Zorina Stroe; Anca Elena Gogu; Daniel Docu Axelerad
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

Review 3.  Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications.

Authors:  Manon Galoppin; Saniya Kari; Sasha Soldati; Arindam Pal; Manon Rival; Britta Engelhardt; Anne Astier; Eric Thouvenot
Journal:  Brain Commun       Date:  2022-06-30

4.  Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.

Authors:  Pavan Bhargava; Kathryn C Fitzgerald; Peter A Calabresi; Ellen M Mowry
Journal:  JCI Insight       Date:  2017-10-05

5.  Narrowband UVB Phototherapy for Clinically Isolated Syndrome: A Trial to Deliver the Benefits of Vitamin D and Other UVB-Induced Molecules.

Authors:  Prue H Hart; Robyn M Lucas; David R Booth; William M Carroll; David Nolan; Judith M Cole; Anderson P Jones; Allan G Kermode
Journal:  Front Immunol       Date:  2017-01-24       Impact factor: 7.561

6.  High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Authors:  Trygve Holmøy; Jonas Christoffer Lindstrøm; Erik Fink Eriksen; Linn Hofsøy Steffensen; Margitta T Kampman
Journal:  BMC Neurol       Date:  2017-04-04       Impact factor: 2.474

Review 7.  A Brief Review of the Effects of Vitamin D on Multiple Sclerosis.

Authors:  Andrei Miclea; Maud Bagnoud; Andrew Chan; Robert Hoepner
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

Review 8.  Iranian consensus on use of vitamin D in patients with multiple sclerosis.

Authors:  Soodeh Razeghi Jahromi; Mohammad Ali Sahraian; Mansoureh Togha; Behnaz Sedighi; Vahid Shayegannejad; Alireza Nickseresht; Shahriar Nafissi; Niayesh Mohebbi; Nastran Majdinasab; Mohsen Foroughipour; Masoud Etemadifar; Nahid Beladi Moghadam; Hormoz Ayramlou; Fereshteh Ashtari; Shekoofe Alaie
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474

9.  Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial.

Authors:  Karen O'Connell; Jamal Sulaimani; Sharee A Basdeo; Katie Kinsella; Sinead Jordan; Orla Kenny; Siobhan B Kelly; David Murphy; Eric Heffernan; Ronan P Killeen; Keith Mulready; Marguerite MacMahon; Jennifer J Brady; Carmel McKenna; Ciaran Muldowney; Lorraine Cassidy; Cathal Walsh; Killian O'Rourke; Niall Tubridy; Chris McGuigan; Jean M Fletcher; Michael Hutchinson
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-21

Review 10.  Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats.

Authors:  Julia Feige; Tobias Moser; Lara Bieler; Kerstin Schwenker; Larissa Hauer; Johann Sellner
Journal:  Nutrients       Date:  2020-03-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.